AboutBusiness
HelpPrivacyTerms
RiepilogoLegale e statoCronologiaReteProprietà e organiSociBeneficiario effettivoGeografiaBilancioSalute finanziariaDocumenti
RiepilogoLegale e statoCronologiaReteProprietà e organiSociBeneficiario effettivoGeografiaBilancioSalute finanziariaDocumenti

B2G LIFE SCIENCES

🇫🇷Francia•Sas, Société Par Actions Simplifiée•Active
Net margin (2024)Net margin
-1,8%
Operating margin (2024)Operating margin
-2,8%
YoY profit / (loss) (2023 vs 2024)YoY profit / (loss)

Riepilogo

Country🇫🇷Francia
StatusActive
Registration Number53288535700030
Founded15/06/2011
Address6 Rue Falconet, Sevres, 92310

Dati legali e stato

Legal FormSas, Société Par Actions Simplifiée
StatusActive
Registration Date15/06/2011
Registry AuthorityINPI
Registered Capital10.000

Source: FR INPI · Last updated: 29/03/2026

Timeline (2 events)

17/01/2025

Hafedh Haddad (person)

Appointed as Officer

15/06/2011

Company incorporated

Incorporation date: 2011-06-15

Rete

Press enter or space to select a node. You can then use the arrow keys to move the node around. Press delete to remove it and escape to cancel.
Press enter or space to select an edge. You can then press delete to remove it or escape to cancel.
Profondità rete

Proprietà e organi

Officers & directors

Hafedh Haddad

Officer

Appointed: 17/01/2025

—

Ownership Timeline

No ownership changes found

Soci (azionariato)

NomePartecipazioneVotoDal
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Beneficiario effettivo

NomePartecipazionePaeseDal
▓▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%
▓▓▓▓▓▓▓▓▓▓
██.██%
██.█%
█.██%
▓▓▓▓▓▓▓▓▓▓▓▓
██.█%
█.██%
██%
▓▓▓▓▓▓▓▓▓▓▓
█.██%
██%
█.█%
▓▓▓▓▓▓▓▓▓▓▓▓▓
██%
█.█%
██.██%
▓▓▓▓▓▓▓▓▓▓
█.█%
██.██%
██.█%

Geografia

Sede

6 Rue Falconet

Sevres

92310

Bilancio e conti

Cifre chiave dai bilanci depositati.

Convert to

2024

Turnover: €249.8K

Key figures

Turnover

2016—
2017—
2022—
2023—
2024€249.750

Profit / (loss)

2016€-9075
2017€5575
2022€-114.869
2023€80.636
2024€-4506

Operating profit

2016—
2017—
2022—
2023—
2024€-7087

Other income

2016—
2017—
2022—
2023—
2024€42

Total assets

2016€587
2017€6204
2022€65.253
2023€77.916
2024€56.405

Share Capital

2016€10.000
2017€10.000
2022€10.000
2023€10.000
2024€10.000
Metric20162017202220232024
Turnover————€249.750
Profit / (loss)€-9075€5575€-114.869€80.636€-4506
Operating profit————€-7087
Other income————€42
Total assets€587€6204€65.253€77.916€56.405
Share Capital€10.000€10.000€10.000€10.000€10.000

Documenti

Document downloads are not available yet for French companies.

Formalité RNE — création 2011-06-15

17/01/2025

Comptes annuels

Accounts for the accounting period ending on: 31/03/2024

Filed: 08/11/2024

Comptes annuels

Accounts for the accounting period ending on: 31/03/2023

Filed: 19/02/2024

Comptes annuels

Accounts for the accounting period ending on: 31/03/2022

Filed: 19/04/2023

Comptes annuels

Accounts for the accounting period ending on: 31/03/2017

Filed: 29/05/2018

Document AI

Coming soon

Companexia Document AI

Ask questions about filings and extracts—our AI will read the documents and answer in context.

Comptes annuels

Accounts for the accounting period ending on: 31/03/2016

Filed: 29/05/2018

Altre aziende e persone

🇮🇪KILDALE LIMITED🇮🇪BRAMBURY LIMITED🇮🇪AVONMOUNT LIMITED🇺🇸Mr Greggory MischnerEDGAR LEE🇬🇧Mr Derek Christopher Williams
-105,6%
Return on assets (net) (2024)Return on assets (net)
-8%
Asset turnover (2024)Asset turnover
4,43×

Financial Health

Derived ratios from annual accounts. Values are omitted when data is missing or not meaningful.

Margins

Net margin (2024)
-1,8%
Operating margin (2024)
-2,8%

Growth

YoY profit / (loss) (2016 vs 2017)
+161,4%
YoY total assets (2016 vs 2017)
+956,9%
YoY profit / (loss) (2017 vs 2022)
-2160,4%
YoY total assets (2017 vs 2022)
+951,8%
YoY profit / (loss) (2022 vs 2023)
+170,2%
YoY total assets (2022 vs 2023)
+19,4%
YoY profit / (loss) (2023 vs 2024)
-105,6%
YoY total assets (2023 vs 2024)
-27,6%
CAGR total assets (2016–2024)
+213,1%

Efficiency & returns

Return on assets (net) (2016)
-1546%
Return on assets (net) (2017)
89,9%
Return on assets (net) (2022)
-176%
Return on assets (net) (2023)
103,5%
Asset turnover (2024)
4,43×
Return on assets (net) (2024)
-8%
  1. Home
  2. –Francia
  3. –Sevres
  4. –B2G LIFE SCIENCES
Return on assets (operating) (2024)
-12,6%